Deerfield Management’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.1M | Sell |
2,067,320
-11,189
| -0.5% | -$147K | 0.49% | 42 |
|
|
2025
Q1 | $45.7M | Hold |
2,078,509
| – | – | 0.9% | 26 |
|
|
2024
Q4 | $55.5M | Buy |
2,078,509
+297,503
| +17% | +$7.94M | 1.05% | 27 |
|
|
2024
Q3 | $47.5M | Sell |
1,781,006
-1,093,580
| -38% | -$29.2M | 0.71% | 31 |
|
|
2024
Q2 | $51.8M | Hold |
2,874,586
| – | – | 0.86% | 29 |
|
|
2024
Q1 | $52.4M | Sell |
2,874,586
-1,058,551
| -27% | -$19.3M | 0.91% | 29 |
|
|
2023
Q4 | $43M | Hold |
3,933,137
| – | – | 0.79% | 33 |
|
|
2023
Q3 | $22.5M | Hold |
3,933,137
| – | – | 0.5% | 41 |
|
|
2023
Q2 | $30.5M | Hold |
3,933,137
| – | – | 0.65% | 36 |
|
|
2023
Q1 | $26.2M | Hold |
3,933,137
| – | – | 0.58% | 45 |
|
|
2022
Q4 | $35.2M | Hold |
3,933,137
| – | – | 0.73% | 41 |
|
|
2022
Q3 | $38.7M | Hold |
3,933,137
| – | – | 0.77% | 44 |
|
|
2022
Q2 | $31.3M | Hold |
3,933,137
| – | – | 0.65% | 47 |
|
|
2022
Q1 | $38.2M | Hold |
3,933,137
| – | – | 0.85% | 37 |
|
|
2021
Q4 | $60.1M | Hold |
3,933,137
| – | – | 1.26% | 25 |
|
|
2021
Q3 | $65.3M | Hold |
3,933,137
| – | – | 1.27% | 22 |
|
|
2021
Q2 | $83.9M | Hold |
3,933,137
| – | – | 1.49% | 13 |
|
|
2021
Q1 | $128M | Buy |
+3,933,137
| New | +$128M | 2.69% | 6 |
|